Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

97.70
Delayed Data
As of May 26
 -0.80 / -0.81%
Today’s Change
96.18
Today|||52-Week Range
157.02
-20.15%
Year-to-Date
Analysts' Actions -- Kellogg, Kraft Heinz, Altria, PayPal and More
May 25 / TheStreet.com - Paid Partner Content
Here's Why Alexion Pharma (ALXN) Stock is Sinking Today
May 23 / Zacks.com - Paid Partner Content
Company News for May 24, 2017
May 24 / Zacks.com - Paid Partner Content
BMO: Too Early to Tell If Alexion's Management Shakeup Bodes Well for Stock
May 23 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data
May 24 / Zacks.com - Paid Partner Content
Biotech Movers: Cerus, Alexion, NantKwest
May 23 / TheStreet.com - Paid Partner Content
Trader's Daily Notebook: As Long Weekend Nears, Volume Will Stay Low
May 24 / TheStreet.com - Paid Partner Content
Alexion's (ALXN) Strensiq Results Positive in Long-Term Study
May 17 / Zacks.com - Paid Partner Content
Alexion Shares Drop Amid Executive Changes
May 23 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer De...
May 17 / Zacks.com - Paid Partner Content